Finally about to start Pyriltamide (ONLY Pyriltamide)
    Chat 8/16/2024

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’ง Pyrilutamide (topical) 0.5% 2x daily
    ๐Ÿ’Š Finasteride (oral) 0.25mg every other day
    the tone is ๐Ÿ˜ neutral.

    Other terms

    A user is excited to start using Pyriltamide for hair loss after experiencing side effects from topical finasteride. Other users discuss the potential and skepticism of Pyriltamide compared to older treatments like finasteride and RU58841.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 850 results

      community Guys, we finally have an alternative to finasteride

      in Research/Science  259 upvotes 2 weeks ago
      A combination of pyrilutamide, minoxidil, and alfatradiol is proposed as an effective alternative to finasteride for treating mild to moderate hair loss, claiming to stabilize hair loss and improve thickness without finasteride's side effects. Some users are skeptical about the effectiveness and approval of these treatments, while others are interested in trying them due to finasteride's side effects.

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 9 months ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.

      community No side effects on pyrilutamide / KX-826 so far

      in Research/Science  209 upvotes 3 years ago
      User TopBack56 and friends tried pyrilutamide (KX-826) for hair loss without experiencing negative side effects. They observed fine vellus hairs but no thick hair growth yet, and plan to add GT20029 to their regime after safety trials.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 1 year ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

    Related Research

    6 / 12 results